arrow
S

Simona Sica

Department of Laboratory and Hematological Sciences
H指数:61
被引数:1.6万
浏览量:0

个人简介

Esperto in presso il dipartimento di del Policlinico Universitario Agostino Gemelli, più grande ospedale di Roma, centro di ricerca e Fondazione IRCCS

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Independent validation of the International Metabolic Prognostic Index (CAR-IMPI) in patients with aggressive diffuse large B-cell lymphoma treated with CAR-T

国际代谢预后指数(CAR-IMPI)在CAR-T治疗的高侵袭性弥漫大B细胞淋巴瘤患者中的独立验证

2026-09-170
OAAI
Early deterioration and subsequent recovery of nursing complexity after CAR-T therapy: a prospective score-based analysis

CAR-T治疗后护理复杂性的早期恶化和后续恢复:一项基于评分的前瞻性分析

2026-09-050
PRE
Real-world approaches to preventing acute myeloid leukemia relapse after allogeneic transplantation: a national survey by GITMO (Gruppo Italiano Trapianto Midollo Osseo)

异基因移植后急性髓系白血病复发的预防策略:GITMO(意大利骨髓移植组)全国调查

2026-08-050
PRE
Lymphodepletion and donor lymphocyte infusions (LD-DLI) for DLI-non responsive myelofibrosis
2026-07-200
PRE
TP53 Mutations Unfavorably Impact the Outcomes of Myelofibrosis Patients with or Without Hematopoietic Stem Cell Transplantation: A Single-Center Study and Meta-Analysis

TP53突变对接受或不接受造血干细胞移植的骨髓纤维化患者结局的不利影响: 一项单中心研究和荟萃分析

2026-05-250
OAAI
Advanced deep learning enables prediction of allogeneic stem cell mobilization success

高级深度学习技术能够预测同种异体干细胞动员的成功率。

2026-03-170
OAAI
A Modified-Delphi Consensus on the Management of Patients with FLT3-Mutated AML

FLT3突变急性髓系白血病患者的管理修改德尔菲共识

Cancers
IF4.4
2026-02-280
OAAI
High Frequency of Germline ATM Variants in Familial Philadelphia-Negative Myeloproliferative Neoplasms

家族性费城阴性骨髓增生性肿瘤中生殖系ATM变异的高频率

2026-02-010
OAAI
Real life use of ravulizumab in Italian patients with paroxysmal nocturnal hemoglobinuria: evidence from the REACTION observational study

意大利阵发性睡眠性血红蛋白尿症患者中拉伏利珠单抗的临床实际应用:来自REACTION观察性研究的证据

2026-01-220
OAAI
Differences between Physicians’ and Nurses’ Perspectives in Defining Core Nursing-Sensitive Outcomes in Adult HSCT and CAR-T Therapy: An Interdisciplinary Italian Delphi Consensus

医师与护士在界定成人HSCT和CAR-T疗法核心护理敏感结局方面的视角差异:一项跨学科意大利德尔菲共识

2025-12-270
PRE
Complications of Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide—A Prospective Study on Behalf of the EBMT Transplant Complications Working Party

haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide的并发症——EBMT移植并发症工作组发起的一项前瞻性研究

2025-12-180
OAAI
Unrelated donor transplantation for relapsed refractory aplastic anemia, with quadruple GvHD prophylaxis

无关供者移植治疗复发难治性再生障碍性贫血,联合四联GvHD预防

2025-12-020
PRE
Donor selection in PTCy haploidentical transplant for acute lymphoblastic leukemia: a study from the ALWP of the EBMT

供者选择在PTCy半相合移植治疗急性淋巴细胞白血病中的应用:一项来自EBMT ALWP的研究

2025-11-250
PRE
Nilotinib versus imatinib with early switch from imatinib to nilotinib to obtain treatment-free remission in newly diagnosed chronic myeloid leukemia patients: the analysis of the first co-primary endpoint

尼洛替尼与伊马替尼治疗新诊断慢性髓性白血病患者的比较,包括早期从伊马替尼转换为尼洛替尼以实现治疗缓解的首次主要终点分析

Leukemia
IF13.4
2025-11-180
OAAI
Use of bone marrow cells is associated with improved outcomes when compared to peripheral blood stem cell after haplo-identical transplants with post transplant cyclophosphamide, a study from of the CTIWP-EBMT

与CTIWP-EBMT的一项研究显示,在采用移植后环磷酰胺的半相合移植中,与外周血干细胞相比,使用骨髓细胞与改善后的结局相关。

2025-11-050
PRE
Venetoclax plus hypomethylating agents as first salvage therapy for myeloid malignancies relapsing after allogeneic HSCT

维奈克拉 plus 低甲基化药物作为异基因HSCT后复发的髓系恶性肿瘤的首次挽救性治疗

2025-10-210
PRE
Outcomes of primary graft failure in acute myeloid leukemia patients following unrelated transplantation with post-transplant cyclophosphamide: a study from the ALWP/EBMT

异基因移植后应用环磷酰胺的急性髓系白血病患者原发移植物衰竭的结局:一项来自ALWP/EBMT的研究

2025-10-180
OA
Time to anti-cancer treatment resumption after SARS-CoV-2 infection in patients with active haematological diseases undergoing combined antiviral treatments

SARS-CoV-2感染后,活动性血液疾病患者在接受联合抗病毒治疗情况下重新开始抗癌治疗的时间

2025-10-010
OAAI
Tracking Inflammation in CAR-T Therapy: The Emerging Role of Serum Amyloid A (SAA)

CAR-T疗法中的炎症监测:血清淀粉样蛋白A(SAA)的兴起作用

2025-09-300
OAAI
Dependence and clinical fragility in hematopoietic stem cell transplant and CAR-T therapy: a retrospective study

依赖性和临床脆弱性在造血干细胞移植和CAR-T疗法中的应用:一项回顾性研究

2025-09-260
OA